farmakovigilanssystemer
Pharmako-vigilance is the practice of monitoring the safety of medicinal products after they have been approved for marketing. It involves the systematic collection, analysis, and interpretation of data on the adverse reactions and other safety issues associated with a particular drug or group of drugs.
The main objective of pharmaco-vigilance is to identify and assess the potential risks associated with a medicinal
Pharmaco-vigilance programs are typically managed by regulatory agencies, such as the Food and Drug Administration (FDA)
The data collected through pharmaco-vigilance is analyzed and interpreted by experts in pharmacology and epidemiology. The
Pharmaco-vigilance is an essential component of the post-marketing surveillance of medicinal products. It helps to ensure